News LumiraDx Limited

Equities

Delayed OTC Markets Other stock markets 09:00:45 29/04/2024 pm IST			5-day change	1st Jan Change
0.0155 ^USD	-8.82%		-4.91%	-75.36%

08/01	Top Midday Decliners	MT
08/01	LumiraDx Limited(OTCPK:LMDX.F) dropped from NASDAQ Composite Index	CI

Top Midday Decliners	09/01	MT
Stocks Commence 2024 Bullish Rally: LMDX, HNRC, BULT, HALB, SPZI	08/01	AQ
LumiraDx Limited(OTCPK:LMDX.F) dropped from NASDAQ Composite Index	08/01	CI
LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th	06/01	GL
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data	02/01	MT
Top Premarket Decliners	02/01	MT
Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform	02/01	AQ
Roche to buy part of LumiraDx diagnostics platform for $295 million	30/12	RE
LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche	30/12	DJ
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche	30/12	GL
LumiraDx : EXPLANATORY NOTE - Form 6-K	30/12	PU
LumiraDx : EXPLANATORY NOTE - Form 6-K	11/12	PU
Wall Street Set to Open Lower Friday as Investors Await Economic Data, Powell Speech	01/12	MT
Investors Look Ahead to Powell Speech as US Futures Trend Lower Friday	01/12	MT
Top Premarket Decliners	01/12	MT
LumiraDx : EXPLANATORY NOTE - Form 6-K	21/11	PU
LumiraDx Limited Announces Resignation of Lu Huang from the Board of Directors	07/11	CI
LumiraDx : EXPLANATORY NOTE - Form 6-K	06/11	PU
LumiraDx Limited Announces Board Appointments	06/11	CI
LumiraDx Limited Appoints Veronique Ameye as the Company?s Chief Executive Officer and General Counsel, Effective as of November 1, 2023	06/11	CI

No results for this search